Synopsis Clinical evidence suggests that radial access should become the default approach for acute coronary syndrome (ACS) patients undergoing invasive management. The present study aims to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin in patients with acute coronary syndrome undergoing invasive management. This week’s “ MED FACT ” discusses a clinical study from The Lancet, “ Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomized controlled trial ”.
Aug 2018. Authors : Marco Valgimigli; Enrico Frigoli; Sergio Leonardi; et al. Key Takeaways: The use of radial access for coronary angiography, followed by percutaneous coronary intervention if indicated, was…
